Clinical Trial Update: Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence [NA]

View source ↗

Summary

A terminated clinical trial evaluated whether initial high-risk HPV viral load can predict persistence of cervical intraepithelial neoplasia grade 1 (CIN1).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Cervical Intraepithelial Neoplasia | NA | Status: TERMINATED